ANZMTG 01.02/TROG 02.01 - TROG Cancer Research

By w.paterson
14 August, 2021
0 Comments

A Randomised Clinical Trial of Surgery Versus Surgery Plus Adjuvant Radiotherapy for Regional Control in Patients With Completely Resected Nodal Metastatic Melanoma

Primary Sponsor

1 October, 2024

A plan for the future of cancer research

12 September 2024: TROG Cancer Research has outlined how

TOPGEAR trial results published in the New England Journal of Medicine

18 September, 2024

TOPGEAR trial findings published in NEJM

18 September 2024: We’re thrilled to announce the release

Join us to raise $20,000

For over 30 years, Trans-Tasman Radiation Oncology Group has been dedicated to improving the way radiation medicine is delivered to cancer patients with ongoing scientific research, clinical trials, and cutting-edge technology.

Quick Links

Legalities

A Randomised Clinical Trial of Surgery Versus Surgery Plus Adjuvant Radiotherapy for Regional Control in Patients With Completely Resected Nodal Metastatic Melanoma

CPRR04-EFC4690/TROG 02.02 – HEADSTART

TROG 01.05 – Superdex/Spinal Cord Compression

Related Post

A plan for the future of cancer research

TOPGEAR trial findings published in NEJM

Join us to raise $20,000